Identifying therapeutic targets for Alzheimer's disease with big data

Medicine & Life Sciences

• Big Data 100%
• Alzheimer Disease 57%
• Neurology 25%
• Endophenotypes 21%
• Neurologists 18%
• Neurosciences 17%
• Therapeutics 12%
• Research Personnel 11%
• Genetic Research 10%
• Organized Financing 9%
• Turkey 8%
• Genetic Association Studies 8%
• Memory Disorders 8%
• Medical Schools 8%
• Internship and Residency 8%
• Amyloid 7%
• African Americans 7%
• Inborn Genetic Diseases 7%
• Transcriptome 7%
• Epigenomics 7%
• Neurodegenerative Diseases 7%
• Quality of Health Care 7%
• Dementia 6%
• Genome 5%
• Peptides 5%
• Gene Expression 4%
• Blood Vessels 4%